<table id="i76c50ce1-7f75-4b89-8711-e95f03ce1c4e" width="50%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 2 Dose to body weight range to achieve similar steady-state exposure (AUC 0-24 hr) to unbound oxaprozin in JRA patients  relative to 70 kg adult rheumatoid arthritis patients administered oxaprozin 1200 mg QD* </caption>
<tbody>
<tr>
<td>
<content stylecode="bold">Dose (mg)</content>
<br/>
</td>
<td>
<content stylecode="bold">Body Weight Range (kg)</content>
<br/>
</td>
</tr>
<tr>
<td>600<br/>
</td>
<td>22 - 31<br/>
</td>
</tr>
<tr>
<td>900<br/>
</td>
<td>32 - 54<br/>
</td>
</tr>
<tr>
<td>1200<br/>
</td>
<td>greater than or equal to 55<br/>
</td>
</tr>
</tbody>
</table>